TEVA logo

TEVA
Teva- Pharmaceutical Industries Ltd. - ADR

26,960
Mkt Cap
$34.16B
Volume
9.32M
52W High
$30.20
52W Low
$12.47
PE Ratio
48.65
TEVA Fundamentals
Price
$29.79
Prev Close
$30.18
Open
$30.00
50D MA
$23.30
Beta
0.83
Avg. Volume
14.71M
EPS (Annual)
-$1.46
P/B
4.71
Rev/Employee
$458,660.10
Loading...
Loading...
News
all
press releases
Teva Pharmaceutical Industries (NYSE:TEVA) VP Sells $3,311,622.24 in Stock
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Get Free Report) VP Richard Daniell sold 115,468 shares of the stock in a transaction dated Tuesday, December 9th. The stock was sold at an average...
MarketBeat·8h ago
News Placeholder
More News
News Placeholder
Teva Pharmaceutical Industries (NYSE:TEVA) Insider Sells $6,231,307.16 in Stock
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Get Free Report) insider Mark Sabag sold 216,892 shares of the stock in a transaction on Tuesday, December 9th. The shares were sold at an average...
MarketBeat·8h ago
News Placeholder
Insider Selling: Teva Pharmaceutical Industries (NYSE:TEVA) VP Sells 115,468 Shares of Stock
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Get Free Report) VP Richard Daniell sold 115,468 shares of the stock in a transaction dated Tuesday, December 9th. The shares were sold at an average...
MarketBeat·17h ago
News Placeholder
Maverick Capital Ltd. Has $73.37 Million Holdings in Teva Pharmaceutical Industries Ltd. $TEVA
Maverick Capital Ltd. lifted its stake in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 14,351.6% during the second quarter, according to its most recent disclosure with...
MarketBeat·18h ago
News Placeholder
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.75 Million Holdings in Teva Pharmaceutical Industries Ltd. $TEVA
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 121.8% in the 2nd quarter...
MarketBeat·2d ago
News Placeholder
Zacks Research Issues Positive Forecast for TEVA Earnings
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) - Equities research analysts at Zacks Research upped their Q2 2026 earnings per share estimates for shares of Teva Pharmaceutical...
MarketBeat·2d ago
News Placeholder
TEVA Files NDA With FDA for Olanzapine LAI for Schizophrenia
Teva files an NDA seeking FDA approval for its once-monthly olanzapine LAI for the treatment of adults with schizophrenia.
Zacks·3d ago
News Placeholder
Zacks Research Issues Pessimistic Estimate for TEVA Earnings
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) - Investment analysts at Zacks Research dropped their Q3 2026 EPS estimates for Teva Pharmaceutical Industries in a report released on...
MarketBeat·3d ago
News Placeholder
Bank of America Raises Teva Pharmaceutical Industries (NYSE:TEVA) Price Target to $32.00
Bank of America raised their price objective on Teva Pharmaceutical Industries from $29.00 to $32.00 and gave the company a "buy" rating in a report on Tuesday...
MarketBeat·4d ago
News Placeholder
Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to Play
Teva holds bullish momentum, trading above key SMAs, as branded drugs and biosimilars drive growth despite generics softness.
Zacks·4d ago

Latest TEVA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.